IThe rapidly expanding number of biotechs focusing on Gene Therapies means many products require manufacturing and distribution to patients. There is no one-size-fits-all solutions for Viral Vector manufacturing. Just like the therapy you develop, you require a tailored approach.

Development

• Translational activities to create GMP compliant manufacturing
• Process design and optimisation
• Scale-up to clinically relevant volumes
• Automation and closed processes

Manufacturing

• Pre-clinical or toxicology study material
• Phase I to Phase III clinical trial material

Viral Vector

Talk to NecstGen today about your needs for:

• Lentiviruses (LV)
• Adeno-associated viruses (AAV)
• Oncolytic viruses